FDANonrulemakingFDA-2014-D-1525

Who commented on this docket

Mixing, Diluting, or Repackaging Biological Products Outside the Scope of an Approved Biologics License Application

3 organizations filed 3 public comments on Mixing, Diluting, or Repackaging Biological Products Outside the Scope of an Approved Biologics License Application, at the Food and Drug Administration. The comment window closed 3523d ago.

Organizations
3
Comments
3
RIN
—
Comment window
closed 3523d ago

Commenters (3)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.

Who Commented on Mixing, Diluting, or Repackaging Biological Products Outside the Scope of an Approved Biologics License Application (FDA-2014-D-1525) | OpenPolis